Market Performance - On July 31, major indices experienced a downward trend, with the Shanghai Composite Index falling by 1.18%, the Shenzhen Component Index down by 1.73%, and the ChiNext Index decreasing by 1.66% [1] - The market saw a total trading volume of nearly 2 trillion yuan, with over 4,200 stocks declining [1] Sector Performance - Sectors that faced significant declines included coal, steel, shipping, oil, chemical fiber, real estate, non-ferrous metals, securities, insurance, aquatic products, and lithium mining [1] - Conversely, the pharmaceutical sector showed strength, with stocks like Nanjing New Pharmaceutical and Anke Bio reaching their daily limit [1] - The assisted reproduction concept and related stocks, such as A-share Gongtong Pharmaceutical and Lide Man, also saw substantial gains, with several stocks hitting their daily limit [6][8] Regulatory and Company News - *ST Guandao announced its stock would resume trading on July 31, 2025, amid risks of being forced to delist due to significant legal violations [3] - The company was under investigation by the China Securities Regulatory Commission (CSRC) since December 4, 2024, and received a notice of administrative penalty on June 13, 2025 [3] Policy Developments - The Beijing Municipal Government issued measures to enhance reproductive health services, including optimizing maternal and child healthcare resources and improving prenatal and postnatal care [8] - As of June 2025, 253 million people participated in maternity insurance, with total fund expenditures reaching 438.3 billion yuan [8] Gold Market Insights - The U.S. Federal Reserve maintained the federal funds rate target range at 4.25% to 4.50% [9] - In the first half of 2025, China's gold jewelry consumption decreased by 26%, while investment demand for gold bars and coins increased by 23.69% [9]
839680，30cm“地天板”！可能强制退市